Emeryville, Ca., USA - April 20, 2010, Emeryville, Ca., USA - Amyris Biotechnologies announced that Arthur Levinson is joining the company's board of directors.
Article continues below
Mr. Levinson serves as chairman of Genentech, Inc., having joined Genentech in 1980 as a research scientist. He became vice president of research technology in 1989, vice president of research in 1990, senior vice president of research in 1992 and senior vice president of research and development in 1993.
Mr. Levinson served as chief executive officer of Genentech from 1995 to 2009, and as chairman of Genentech since 1999. Levinson is a member of Genentech’s Scientific Research Board, which serves as an advisory group to the company regarding its research and early development projects.
Mr. Levinson is a director of Apple, Inc. and a director of NGM Biopharmaceuticals. He also serves on the Board of Scientific Consultants of the Memorial Sloan-Kettering Cancer Center, on the Industrial Advisory Board of the California Institute for Quantitative Biomedical Research, on the Advisory Council for the Princeton University Department of Molecular Biology, on the Advisory Council for the Lewis-Sigler Institute for Integrative Genomics, and on the Executive Council of TechNet.
Mr. Levinson has authored or co-authored more than 80 scientific articles and has been a named inventor on 11 United States patents. Mr. Levinson was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of Chief Executive Officers.
BusinessWeek named Mr. Levinson one of the “Best Managers of the Year†in 2004 and 2005, and Institutional Investor named him “America’s Best CEO†in the biotech category four years in a row (2004-2007).
In 2006, Princeton University awarded Mr. Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. Also in 2006, Barron’s recognized Levinson as one of “The World’s Most Respected CEOs,†and the Best Practice Institute placed Levinson on their “25 Top CEOs†list. ■